Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
DFHTU was delisted on the 8th of June, 2021.
0 hedge funds and large institutions have $0 invested in Deerfield Healthcare Technology Acquisitions Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.
100% less funds holding
Funds holding: 10 → 0 (-10)
100% less capital invested
Capital invested by funds: $12.5M → $0 (-$12.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$4.56M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.93M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$3.01M |
| 4 |
SCM
Sio Capital Management
New York
|
-$655K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$265K |
DFHTU Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Deerfield Healthcare Technology Acquisitions Corp. Unit (DFHTU) for Q2 2021, worth a combined $0 — down 100% from $12.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of DFHTU and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Parian Global Management, exiting entirely with an estimated $4.56M sold.
- 0 institutional investors held Deerfield Healthcare Technology Acquisitions Corp. Unit (DFHTU) as of Q2 2021, down from 10 in Q1 2021.
- Funds reported $0 of Deerfield Healthcare Technology Acquisitions Corp. Unit stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Deerfield Healthcare Technology Acquisitions Corp. Unit positions in Q2 2021 and 10 closed out, a net change of -10 holders.
- The largest Deerfield Healthcare Technology Acquisitions Corp. Unit seller in Q2 2021 was Parian Global Management, an estimated $4.56M sold.
Based on aggregated 13F filings for Q2 2021.